Simonetta Masieri

1.2k total citations
70 papers, 662 citations indexed

About

Simonetta Masieri is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Simonetta Masieri has authored 70 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Physiology, 32 papers in Immunology and Allergy and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Simonetta Masieri's work include Allergic Rhinitis and Sensitization (32 papers), Asthma and respiratory diseases (30 papers) and Sinusitis and nasal conditions (18 papers). Simonetta Masieri is often cited by papers focused on Allergic Rhinitis and Sensitization (32 papers), Asthma and respiratory diseases (30 papers) and Sinusitis and nasal conditions (18 papers). Simonetta Masieri collaborates with scholars based in Italy, United States and Lebanon. Simonetta Masieri's co-authors include Franco Cavaliere, Carlo Cavaliere, Cristoforo Incorvaia, Franco Frati, Giorgio Conti, Andrea Ciofalo, Antonio Greco, Rodolfo Proietti, R. Proietti and Marco de Vincentiis and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Simonetta Masieri

64 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simonetta Masieri Italy 15 265 238 190 147 124 70 662
Carlo Capristo Italy 18 274 1.0× 155 0.7× 204 1.1× 22 0.1× 93 0.8× 57 769
Manlio Milanese Italy 23 1.2k 4.4× 544 2.3× 843 4.4× 67 0.5× 85 0.7× 72 1.4k
Françoise Zerah-Lancner France 18 568 2.1× 79 0.3× 555 2.9× 76 0.5× 186 1.5× 29 922
Matthew G. Drake United States 15 432 1.6× 52 0.2× 386 2.0× 5 0.0× 142 1.1× 47 886
Francesca Occasi Italy 17 258 1.0× 129 0.5× 134 0.7× 30 0.2× 94 0.8× 24 511
Omer Khair United Kingdom 14 486 1.8× 127 0.5× 408 2.1× 13 0.1× 39 0.3× 19 838
Ertap Akoğlu Türkiye 15 106 0.4× 24 0.1× 53 0.3× 118 0.8× 221 1.8× 36 507
Samet Özlügedik Türkiye 17 146 0.6× 35 0.1× 112 0.6× 123 0.8× 350 2.8× 39 603
Yue-Shih Chen Germany 13 190 0.7× 14 0.1× 68 0.4× 71 0.5× 85 0.7× 19 440
J Claes Belgium 14 85 0.3× 24 0.1× 85 0.4× 143 1.0× 162 1.3× 42 632

Countries citing papers authored by Simonetta Masieri

Since Specialization
Citations

This map shows the geographic impact of Simonetta Masieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simonetta Masieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simonetta Masieri more than expected).

Fields of papers citing papers by Simonetta Masieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simonetta Masieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simonetta Masieri. The network helps show where Simonetta Masieri may publish in the future.

Co-authorship network of co-authors of Simonetta Masieri

This figure shows the co-authorship network connecting the top 25 collaborators of Simonetta Masieri. A scholar is included among the top collaborators of Simonetta Masieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simonetta Masieri. Simonetta Masieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cavaliere, Carlo, et al.. (2025). Remission in chronic rhinosinusitis with nasal polyps treated with biologics: a real-life experience. European Archives of Oto-Rhino-Laryngology. 282(9). 4681–4690.
3.
Nuccetelli, Marzia, et al.. (2025). Nasal cytological evidence of chronic inflammation in the olfactory cleft in post-viral olfactory dysfunction. European Archives of Oto-Rhino-Laryngology. 282(5). 2389–2397.
4.
Ciofalo, Andrea, et al.. (2024). Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with Dupilumab. European Archives of Oto-Rhino-Laryngology. 281(12). 6511–6521. 4 indexed citations
6.
Cavaliere, Carlo, et al.. (2024). Real-Life Evidence of Mepolizumab Treatment in Chronic Rhinosinusitis with Nasal Polyps: A Multicentric Study. Journal of Clinical Medicine. 13(12). 3575–3575. 7 indexed citations
7.
Ciofalo, Andrea, et al.. (2023). Dupilumab’s Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life. Journal of Immunology Research. 2023. 1–10. 12 indexed citations
8.
Cavaliere, Carlo, et al.. (2023). The Impact of Antibiotics and Steroids on the Nasal Microbiome in Patients with Chronic Rhinosinusitis: A Systematic Review According to PICO Criteria. Journal of Personalized Medicine. 13(11). 1583–1583. 9 indexed citations
9.
Ciofalo, Andrea, Carlo Cavaliere, Simonetta Masieri, et al.. (2022). Long-Term Subjective and Objective Assessment of Smell and Taste in COVID-19. Cells. 11(5). 788–788. 14 indexed citations
10.
Cavaliere, Carlo, Marco Segatto, Andrea Ciofalo, et al.. (2022). Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study.. Immunology Letters. 248. 70–77. 12 indexed citations
11.
Masieri, Simonetta, Claus Bachert, Pedro Ojeda, et al.. (2021). Allergen Immunotherapy management during vaccinations: An international survey. World Allergy Organization Journal. 14(11). 100601–100601. 6 indexed citations
12.
Cavaliere, Carlo, Simonetta Masieri, Antonio Greco, Alessandro Lambìase, & Marco Segatto. (2021). Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis. Annals of Allergy Asthma & Immunology. 126(4). 442–443. 11 indexed citations
13.
Cavaliere, Carlo, Cristoforo Incorvaia, Bruno Sposato, et al.. (2020). Long-term omalizumab efficacy in allergic rhinitis. Immunology Letters. 227. 81–87. 18 indexed citations
14.
Cavaliere, Carlo, Cristoforo Incorvaia, Franco Frati, et al.. (2019). Recovery of smell sense loss by mepolizumab in a patient allergic to Dermatophagoides and affected by chronic rhinosinusitis with nasal polyps. Clinical and Molecular Allergy. 17(1). 3–3. 8 indexed citations
15.
Sposato, Bruno, Manlio Milanese, Simonetta Masieri, et al.. (2018). Factors reducing omalizumab response in severe asthma. European Journal of Internal Medicine. 52. 78–85. 49 indexed citations
16.
Watanabe, Mikiko, Simonetta Masieri, Daniela Costantini, et al.. (2018). Overweight and obese patients with nickel allergy have a worse metabolic profile compared to weight matched non-allergic individuals. PLoS ONE. 13(8). e0202683–e0202683. 31 indexed citations
17.
Cavaliere, Franco, Simonetta Masieri, Giorgio Conti, et al.. (2003). Effects of non-invasive ventilation on middle ear function in healthy volunteers. Intensive Care Medicine. 29(4). 611–614. 16 indexed citations
18.
Cavaliere, Franco & Simonetta Masieri. (2002). Furosemide Protective Effect Against Airway Obstruction. Current Drug Targets. 3(3). 197–201. 11 indexed citations
19.
Orlando, Maria Patrizia, et al.. (1997). Sudden Hearing Loss in Childhood Consequent to Hepatitis B Vaccination: A Case Report. Annals of the New York Academy of Sciences. 830(1). 319–321. 10 indexed citations
20.
Cavaliere, Franco, et al.. (1992). Tympanometry for middle-ear effusion in unconscious ICU patients.. PubMed. 9(1). 71–5. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026